These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19696300

  • 1. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
    Tozaki M, Fukuma E.
    AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
    [Abstract] [Full Text] [Related]

  • 2. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H.
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [Abstract] [Full Text] [Related]

  • 3. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [Abstract] [Full Text] [Related]

  • 4. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG, Ai V, Chan JK, Li KW, Cheung PS, Wong TT, Ma M, Lee R, Chien D.
    J Comput Assist Tomogr; 2009 Nov; 33(1):63-9. PubMed ID: 19188787
    [Abstract] [Full Text] [Related]

  • 5. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
    Bogner W, Pinker K, Zaric O, Baltzer P, Minarikova L, Porter D, Bago-Horvath Z, Dubsky P, Helbich TH, Trattnig S, Gruber S.
    Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078
    [Abstract] [Full Text] [Related]

  • 6. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD.
    AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
    [Abstract] [Full Text] [Related]

  • 7. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
    Bartella L, Thakur SB, Morris EA, Dershaw DD, Huang W, Chough E, Cruz MC, Liberman L.
    Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
    [Abstract] [Full Text] [Related]

  • 8. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL, Rahmat K, Rozalli FI, Mohd-Shah MN, Aziz YF, Yip CH, Vijayananthan A, Ng KH.
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [Abstract] [Full Text] [Related]

  • 9. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.
    Woodhams R, Kakita S, Hata H, Iwabuchi K, Umeoka S, Mountford CE, Hatabu H.
    AJR Am J Roentgenol; 2009 Jul; 193(1):260-6. PubMed ID: 19542422
    [Abstract] [Full Text] [Related]

  • 10. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K, Tsougos I, Kousi E, Vlychou M, Athanasiou E, Theodorou K, Arvanitis DL, Fezoulidis IV.
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [Abstract] [Full Text] [Related]

  • 11. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, Guido J, Huang W.
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [Abstract] [Full Text] [Related]

  • 12. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH, Hsu SS, Ding SW, Ko CW, Fu JH, Weng MJ, Yeh LR, Wu MT, Liang HL, Chen CK, Pan HB.
    Surg Neurol; 2007 Jun; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [Abstract] [Full Text] [Related]

  • 13. Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions.
    Orguc S, Basara I, Coskun T.
    Singapore Med J; 2012 Nov; 53(11):737-43. PubMed ID: 23192501
    [Abstract] [Full Text] [Related]

  • 14. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [Abstract] [Full Text] [Related]

  • 15. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions.
    Ouyang Z, Ouyang Y, Zhu M, Lu Y, Zhang Z, Shi J, Li X, Ren G.
    Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698
    [Abstract] [Full Text] [Related]

  • 16. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H, Kizilgöz V, Tatar IG, Damar C, Ugan AR, Paker I, Hekimoğlu B.
    J Comput Assist Tomogr; 2012 Aug; 36(1):30-45. PubMed ID: 22261768
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
    Yoo H, Shin HJ, Baek S, Cha JH, Kim H, Chae EY, Kim HH.
    Magn Reson Imaging; 2014 Sep; 32(7):867-74. PubMed ID: 24907855
    [Abstract] [Full Text] [Related]

  • 18. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ.
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [Abstract] [Full Text] [Related]

  • 19. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G, Koc Z, Karadeli E, Kuzgunbay B, Goren MR, Bal N.
    Acta Radiol; 2012 Apr 01; 53(3):359-65. PubMed ID: 22334870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.